NGM Biopharmaceuticals Aktie
1,40
EUR
-2,04
EUR
-59,30
%
NGM Biopharmaceuticals Aktie Analyse
29.04.19 | NGM Biopharmaceuticals Outperform | Cowen and Company, LLC |